Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Bimosiamose disodium

EU orphan designation number: EU/3/05/285   
Active ingredient: Bimosiamose disodium
Indication: Treatment of acute lung injury
Sponsor: Revotar Biopharmaceuticals AG
Neuendorfstraße 24a, 16761 Hennigsdorf, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/05/2005 Orphan designation EMEA/OD/006/05 (2005)1664 of 27/05/2005